725 related articles for article (PubMed ID: 15653389)
21. A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation.
Takeda K; Morioka D; Matsuo K; Endo I; Sekido H; Moroboshi T; Togo S; Shimada H
Transplant Proc; 2007 Dec; 39(10):3505-8. PubMed ID: 18089422
[TBL] [Abstract][Full Text] [Related]
22. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
[TBL] [Abstract][Full Text] [Related]
23. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C
J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810
[TBL] [Abstract][Full Text] [Related]
24. Aspergillus infection complicating cardiac transplantation. Report of five cases.
Gurwith MJ; Stinson EB; Remington JS
Arch Intern Med; 1971 Oct; 128(4):541-5. PubMed ID: 4939230
[No Abstract] [Full Text] [Related]
25. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
Pagano L; Valentini CG; Fianchi L; Caira M
J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Stratakos G; Zakynthinos S
Respiration; 2007; 74(6):609-10. PubMed ID: 18037812
[No Abstract] [Full Text] [Related]
27. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
[TBL] [Abstract][Full Text] [Related]
28. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Wingard JR; Herbrecht R; Mauskopf J; Schlamm HT; Marciniak A; Roberts CS
Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
[TBL] [Abstract][Full Text] [Related]
29. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
de Sévaux RG; Kullberg BJ; Verweij PE; van de Nes JA; Meis JF; van der Meer JW
Clin Infect Dis; 1998 Apr; 26(4):996-7. PubMed ID: 9564492
[No Abstract] [Full Text] [Related]
30. A vascular graft infection by aspergillus treated without graft removal.
Del Ponte S; Zingarelli E; Flocco R; Sansone F; Punta G; Bardi G; Parisi F; Forsennati P; Actis Dato GM; Casabona R
Minerva Chir; 2011 Feb; 66(1):74-5. PubMed ID: 21389928
[No Abstract] [Full Text] [Related]
31. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
32. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
33. Voriconazole versus amphotericin B for invasive aspergillosis.
Blot F; Edé C; Nitenberg GM
N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
[No Abstract] [Full Text] [Related]
34. Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Huang HD; Li Q; Huang Y; Bai C; Wu N; Wang Q; Yao XP; Chen B
Chin Med J (Engl); 2012 Apr; 125(7):1236-41. PubMed ID: 22613594
[TBL] [Abstract][Full Text] [Related]
35. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary aspergillosis in an immunocompetent patient.
Ko JP; Kim DH; Shepard JA
J Thorac Imaging; 2002 Jan; 17(1):70-3. PubMed ID: 11828215
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Ouchi H; Fujita M; Ikegame S; Inoshima I; Harada E; Nakanishi Y
J Infect Chemother; 2007 Aug; 13(4):258-62. PubMed ID: 17721689
[TBL] [Abstract][Full Text] [Related]
38. Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Shlobin OA; Dropulic LK; Orens JB; Mcdyer JF; Conte JV; Yang SY; Girgis R
J Heart Lung Transplant; 2005 Nov; 24(11):1991-4. PubMed ID: 16297812
[TBL] [Abstract][Full Text] [Related]
39. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
40. Aortic thrombus during invasive aspergillosis in a kidney transplant recipient.
Abderrahim E; Ben Abdallah T; Aouina H; Ben Maïz H; Kheder A
J Postgrad Med; 2008; 54(1):62-3. PubMed ID: 18296818
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
